GIVE
The MRF at 25
In 2021, the MRF celebrates 25 years of service to the melanoma community, all made possible by your support. Ring in the new year and help us fund the future with a tax-deductible gift today.
Advocacy
2021 Advocacy Days
Register Today!
Advocacy
2021 Advocacy Days
Save the date for the largest melanoma advocacy event of the year on March 1-5, 2021! Registration for this free, virtual event opens on December 7, 2020.
Research & Science
Apply for 2021 Research Funding
Research & Science
Apply for 2021 Research Funding
The MRFBC-BMS Young Investigator Team Award Request for Proposals (RFP) is now available! Applications are accepted January 4 – March 15, 2021.
Advocacy
Congress Passes $30 Million in Defense-Funded Melanoma Research
Advocacy
Congress Passes $30 Million in Defense-Funded Melanoma Research
On Monday, December 21, 2020, both Houses of Congress passed the final version of the FY 2021 Department of Defense (DOD) Appropriations bill and included $30 million for melanoma research within the Congressionally Directed Medical Research Program (CDMRP). The $30 million for the Peer Reviewed Melanoma Research Program is a $10 million increase over FY 2020 appropriations.
Patients & Caregivers
COVID-19 Vaccine and Melanoma
Patients & Caregivers
COVID-19 Vaccine and Melanoma
BREAKING NEWS: SITC Recommendations for COVID-19 Vaccination & Cancer Immunotherapy.
Patients & Caregivers
NEW: Online Patient Forum
Patients & Caregivers
NEW: Online Patient Forum
Visit the newly updated and fully modern MRF Patient Forum to ask questions, seek practical advice and find support. Join the conversation today!
The MRF’s mission is to eradicate melanoma by accelerating medical RESEARCH while EDUCATING to and ADVOCATING for the melanoma community.
Melanoma is the deadliest form of skin cancer.
Melanoma claims the lives of nearly 7,000 Americans every year.
Melanoma is the leading cause of cancer death in young women ages 25 – 30 and the second leading cause of cancer death in women ages 30-35.
9 out of 10 cases are considered to be preventable.
Funding Melanoma Research
Funding from The MRF has resulted in:
22 Clinical trials
83 Grants with new collaborations
204 Publications
409 Presentations
Recent Funded Research Recipients
Career Development Award 2020
Zachary Schug, PhD
The Wistar Institute
Established Investigator Award 2020
Thorsten Mempel, MD, PhD
Massachusetts General Hospital
Established Investigator Award 2020
Linda Malkas, PhD
Beckman Research Institute of the City of Hope
Team Award 2020
Diwakar Davar, MD
University of Pittsburgh (Mentor: Hassane Zarour, MD)
FEATURED EVENT
Virtual 2021 Advocacy Days
March 1 – 5, 2021
Virtual Advocacy Days
March 1 – 5, 2021
Registration is FREE and open on Monday, December 7, 2020
Optimize Your Treatment
Although the MRF cannot recommend a specific doctor, clinic or clinical trial, the Melanoma Treatment Center Finder and Clinical Trial Finder will help you find an experienced melanoma treatment team, as well as give you the opportunity to explore clinical trials. Did you know that clinical trials are often viewed as the best treatment option for Stage II, III and IV melanoma patients?
Please remember to use this information as a starting point in your search for a healthcare team that best meets your needs. All information regarding your treatment should be discussed with your healthcare professional.
Patient
Resources
The MRF is committed to providing the most up-to-date education and support resources for melanoma patients and their loved ones.
